NCT02130531View on ClinicalTrials.gov

Pharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular Degeneration

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

November 30, 2015

Conditions
Geographic AtrophyAge-Related Macular Degeneration
Interventions
DRUG

Emixustat HCl Tablet

Tablet for oral administration

OTHER

Placebo Tablet

Tablet for oral administration

Trial Locations (1)

98101

Call Acucela Clinical Trials Helpdesk for locations, Seattle

Sponsors

Lead Sponsor

Kubota Vision Inc.
All Listed Sponsors
lead

Kubota Vision Inc.

INDUSTRY

NCT02130531 - Pharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular Degeneration | Biotech Hunter | Biotech Hunter